☆ 4.7 Article

Statin therapy in individuals with intermediate cardiovascular risk

METABOLISM-CLINICAL AND EXPERIMENTAL (2024)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Cardiac & Cardiovascular Systems

Cardiovascular Risk and Treatment Outcomes in Severe Hypercholesterolemia: A Nationwide Cohort Study

Chan Joo Lee et al.

Summary: This study evaluated the cardiovascular risk and outcomes after lipid reduction in patients with severe hypercholesterolemia using a nationwide cohort. The results showed incrementally elevated cardiovascular risk and clinical benefit associated with LDL-C<100 mg/dL in individuals with severe hypercholesterolemia, supporting aggressive lipid lowering.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2022)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

Statin therapy for the primary prevention of cardiovascular disease: Cons

Vivek Durai et al.

Summary: Although the mortality rate of cardiovascular disease has decreased, heart disease remains the leading cause of death in both the United States and globally. However, the use of statins does not have the expected benefits. Healthy patients without cardiovascular disease who are prescribed statins do not live longer, and the reduction in ischemic risk is minimal. Moreover, statins have numerous side effects that limit their net benefit.

ATHEROSCLEROSIS (2022)

添加到收藏夹

Article Peripheral Vascular Disease

Statin Therapy in HIGH-Risk Individuals with NORMal Coronary Arteries: The HIGH-NORM Study

Kyeong-Hyeon Chun et al.

Summary: Statin use was not associated with cardiovascular risk reduction in high-risk individuals with normal or near normal coronary arteries.

JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2022)

添加到收藏夹

Review Medicine, General & Internal

Statin Use for the Primary Prevention of Cardiovascular Disease in Adults US Preventive Services Task Force Recommendation Statement

Carol M. Mangione et al.

Summary: Cardiovascular disease is the leading cause of morbidity and death in the US. For adults aged 40 to 75 years with no history of CVD but with one or more CVD risk factors, statin use has at least a moderate net benefit in reducing CVD events and all-cause mortality. However, there is insufficient evidence to assess the benefits and harms of statin use for primary prevention of CVD in adults aged 76 years or older.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)

Francois Mach et al.

EUROPEAN HEART JOURNAL (2020)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Equalization of four cardiovascular risk algorithms after systematic recalibration: individual-participant meta-analysis of 86 prospective studies

Lisa Pennells et al.

EUROPEAN HEART JOURNAL (2019)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary

Scott M. Grundy et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Assessing gaps in cholesterol treatment guidelines for primary prevention of cardiovascular disease based on available randomised clinical trial evidence: The Rotterdam Study

Jelena Pavlovic et al.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2018)

添加到收藏夹

Article Pharmacology & Pharmacy

Effectiveness of Statins as Primary Prevention in People With Different Cardiovascular Risk: A Population-Based Cohort Study

Maria Garcia-Gil et al.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2018)

添加到收藏夹

Article Peripheral Vascular Disease

Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017

Makoto Kinoshita et al.

JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2018)

添加到收藏夹

Review Medicine, General & Internal

Statins for Prevention of Cardiovascular Disease in Adults Evidence Report and Systematic Review for the US Preventive Services Task Force

Roger Chou et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)

添加到收藏夹

Article Medicine, General & Internal

Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease

S. Yusuf et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

添加到收藏夹

Article Medicine, General & Internal

Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials

Jordan Fulcher et al.

LANCET (2015)

添加到收藏夹

Correction Medicine, General & Internal

Reduced dietary salt for the prevention of cardiovascular disease (Withdrawn

Alma J. Adler et al.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2013)

添加到收藏夹

Article Medicine, General & Internal

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

C. Baigent et al.

LANCET (2010)

添加到收藏夹

Article Medicine, General & Internal

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

Paul M. Ridker et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

添加到收藏夹

Article Medicine, General & Internal

Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial

Haruo Nakamura et al.

LANCET (2006)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

SM Grundy et al.

CIRCULATION (2004)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.